Intrinsic Value of S&P & Nasdaq Contact Us

Cronos Group Inc. CRON NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
$7.81
+203.9%
Analyst Price Target
$2.30
-10.5%

Cronos Group Inc. (CRON) has a consensus analyst rating of Hold, based on 15 analysts covering the stock. Of those, 3 recommend buying, 9 recommend holding, and 3 recommend selling.

The analyst consensus price target for CRON is $2.30, representing a -10.5% downside from the current price of $2.57. Price targets range from a low of $2.30 to a high of $2.30.

Analyst Consensus — CRON

Hold
Strong Buy
0
Buy
3
Hold
9
Sell
3
Strong Sell
0
15 analysts
Price Targets
Consensus$2.30
High$2.30
Low$2.30
Median$2.30
Last Month Avg-
Last Quarter Avg$2.30
Last Year Avg$2.30
All-Time Count4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message